A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)
Takeda
Takeda
University Hospital, Toulouse
Stichting Hemato-Oncologie voor Volwassenen Nederland
The First Affiliated Hospital of Soochow University
Astex Pharmaceuticals, Inc.
Kyowa Kirin Co., Ltd.
Genentech, Inc.
Oxford University Hospitals NHS Trust
City of Hope Medical Center
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Celgene
Novartis
Abramson Cancer Center at Penn Medicine
H. Lee Moffitt Cancer Center and Research Institute
Swiss Cancer Institute
Swiss Cancer Institute
M.D. Anderson Cancer Center
Genentech, Inc.
Roswell Park Cancer Institute
University of Kansas Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Arkansas
M.D. Anderson Cancer Center
Cancer Trials Ireland
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Mayo Clinic
Mayo Clinic
Scios, Inc.
University of Arkansas
University of Turin, Italy